相关实验视频

Updated: Jun 20, 2025

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy
08:01

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy

Published on: August 17, 2018

8.3K

一个罕见的毒性肌肉炎病例与流感疫苗接种有关

Sadia Aslam1, Omair Khan1, Joseph Mehrabi1

  • 1Department of Medicine, Maimonides Medical Center, Brooklyn, NY, USA.

Journal of community hospital internal medicine perspectives
|July 22, 2024
PubMed
概括

一个罕见的肌肉炎症病例,一种炎症性肌肉疾病,发生在接受流感疫苗后的一名老年男性身上. 及时的类固醇治疗导致了完全康复,强调了持续接种疫苗的重要性.

关键词:
扩散性肌肉炎是什么接种流感疫苗,接种流感疫苗.接种流感疫苗可以预防流感.肌肉病症 肌肉病症是指肌肉病症.有毒的肌肉炎 有毒的肌肉炎

更多相关视频

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

16.8K
Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

28.4K

相关概念视频

Vaccinations01:51

Vaccinations

Overview
44.3K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
732
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K